185 related articles for article (PubMed ID: 17967001)
1. Synthesis of bicyclic sigma receptor ligands with cytotoxic activity.
Geiger C; Zelenka C; Weigl M; Fröhlich R; Wibbeling B; Lehmkuhl K; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
J Med Chem; 2007 Nov; 50(24):6144-53. PubMed ID: 17967001
[TBL] [Abstract][Full Text] [Related]
2. Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity.
Holl R; Schepmann D; Fröhlich R; Grünert R; Bednarski PJ; Wünsch B
J Med Chem; 2009 Apr; 52(7):2126-37. PubMed ID: 19243173
[TBL] [Abstract][Full Text] [Related]
3. Relationships between the structure of 6-substituted 6,8-diazabicyclo[3.2.2]nonan-2-ones and their sigma receptor affinity and cytotoxic activity.
Holl R; Schepmann D; Bednarski PJ; Grünert R; Wünsch B
Bioorg Med Chem; 2009 Feb; 17(4):1445-55. PubMed ID: 19196515
[TBL] [Abstract][Full Text] [Related]
4. Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activity.
Holl R; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
Bioorg Med Chem; 2009 Jan; 17(2):777-93. PubMed ID: 19081725
[TBL] [Abstract][Full Text] [Related]
5. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of conformationally restricted σ(1) receptor ligands with 7,9-diazabicyclo[4.2.2]decane scaffold.
Sunnam SK; Schepmann D; Rack E; Fröhlich R; Korpis K; Bednarski PJ; Wünsch B
Org Biomol Chem; 2010 Dec; 8(24):5525-40. PubMed ID: 20953473
[TBL] [Abstract][Full Text] [Related]
7. Rigidity versus Flexibility: Is This an Issue in σ1 Receptor Ligand Affinity and Activity?
Weber F; Brune S; Börgel F; Lange C; Korpis K; Bednarski PJ; Laurini E; Fermeglia M; Pricl S; Schepmann D; Wünsch B
J Med Chem; 2016 Jun; 59(11):5505-19. PubMed ID: 27156565
[TBL] [Abstract][Full Text] [Related]
8. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD
J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796
[TBL] [Abstract][Full Text] [Related]
11. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
[TBL] [Abstract][Full Text] [Related]
12. Structure-affinity-relationship study of bicyclic sigma receptor ligands.
Holl R; Geiger C; Nambo M; Itami K; Schepmann D; Wünsch B
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):220-9. PubMed ID: 20021356
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity of a salicylihalamide A analogue.
Tang S; Erickson KL
J Nat Prod; 2008 May; 71(5):898-901. PubMed ID: 18407694
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric synthesis of 9-alkyl-2-benzyl-6,7-benzomorphans: characterization as novel sigma receptor ligands.
Carroll FI; Bai X; Dehghani A; Mascarella SW; Williams W; Bowen WD
J Med Chem; 1999 Nov; 42(22):4621-9. PubMed ID: 10579824
[TBL] [Abstract][Full Text] [Related]
15. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
[TBL] [Abstract][Full Text] [Related]
16. Novel sigma receptor ligands: synthesis and biological profile.
Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of bridged piperazines with sigma receptor affinity.
Weigl M; Wünsch B
Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands.
Vangveravong S; Xu J; Zeng C; Mach RH
Bioorg Med Chem; 2006 Oct; 14(20):6988-97. PubMed ID: 16837201
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives.
Siwy M; Sek D; Kaczmarczyk B; Jaroszewicz I; Nasulewicz A; Pelczyñska M; Nevozhay D; Opolski A
J Med Chem; 2006 Jan; 49(2):806-10. PubMed ID: 16420065
[TBL] [Abstract][Full Text] [Related]
20. 2,6,9-Triazabicyclo[3.3.1]nonanes as overlooked amino-modification products by acrolein.
Tsutsui A; Tanaka K
Org Biomol Chem; 2013 Nov; 11(41):7208-11. PubMed ID: 24057436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
